Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Equity (2020 - 2025)

Mirum Pharmaceuticals has reported Return on Equity over the past 6 years, most recently at 0.08% for Q4 2025.

  • Quarterly results put Return on Equity at 0.08% for Q4 2025, up 31.0% from a year ago — trailing twelve months through Dec 2025 was 0.08% (up 31.0% YoY), and the annual figure for FY2025 was 0.09%, up 28.0%.
  • Return on Equity for Q4 2025 was 0.08% at Mirum Pharmaceuticals, up from 0.15% in the prior quarter.
  • Over the last five years, Return on Equity for MIRM hit a ceiling of 0.08% in Q4 2025 and a floor of 2.35% in Q3 2021.
  • Median Return on Equity over the past 5 years was 0.62% (2022), compared with a mean of 0.73%.
  • Biggest five-year swings in Return on Equity: skyrocketed 205bps in 2022 and later tumbled -112bps in 2023.
  • Mirum Pharmaceuticals' Return on Equity stood at 0.95% in 2021, then increased by 9bps to 0.87% in 2022, then grew by 28bps to 0.63% in 2023, then surged by 39bps to 0.38% in 2024, then surged by 80bps to 0.08% in 2025.
  • The last three reported values for Return on Equity were 0.08% (Q4 2025), 0.15% (Q3 2025), and 0.24% (Q2 2025) per Business Quant data.